{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:15:29Z","timestamp":1790129729035,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM008562"],"award-info":[{"award-number":["T32GM008562"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajog.2025.09.029","type":"journal-article","created":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T09:03:17Z","timestamp":1771059797000},"page":"752-769","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Azithromycin in preterm premature rupture of membranes: population pharmacokinetics and dose optimization"],"prefix":"10.1016","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3705-6943","authenticated-orcid":false,"given":"Rupsa C.","family":"Boelig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viren","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Rochani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gagan","family":"Kaushal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Roman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K.","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2025.09.029_bib1","first-page":"1","article-title":"National vital statistics reports births: final data for 2019","volume":"70","author":"Martin","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2025.09.029_bib2","volume":"12","author":"Kenyon","year":"2013"},{"key":"10.1016\/j.ajog.2025.09.029_bib3","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1097\/AOG.0000000000003700","article-title":"Prelabor rupture of membranes: ACOG practice bulletin, number 217","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.ajog.2021.12.262","article-title":"Erythromycin vs azithromycin for treatment of preterm prelabor rupture of membranes: a systematic review and meta-analysis","volume":"226","author":"Seaman","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0038-1667369","article-title":"Cost analysis of azithromycin versus erythromycin in pregnancies complicated by preterm premature rupture of membranes","volume":"36","author":"Finneran","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2025.09.029_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pharmthera.2014.03.003","article-title":"Azithromycin: mechanisms of action and their relevance for clinical applications","volume":"143","author":"Parnham","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajog.2025.09.029_bib7","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2165\/00003088-199325050-00003","article-title":"Azithromycin clinical pharmacokinetics","volume":"25","author":"Lalak","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2025.09.029_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mob.2003.141","article-title":"Maternal and transplacental pharmacokinetics of azithromycin","volume":"188","author":"Ramsey","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib9","doi-asserted-by":"crossref","first-page":"812.e1","DOI":"10.1016\/j.ajog.2015.01.015","article-title":"Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis","volume":"212","author":"Sutton","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib10","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/cts.13111","article-title":"Longitudinal evaluation of azithromycin and cytokine concentrations in amniotic fluid following one-time oral dosing in pregnancy","volume":"14","author":"Boelig","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.ajog.2025.09.029_bib11","first-page":"187","article-title":"ACOG practice bulletin No. 188 prelabor rupture of membranes","volume":"131","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2024.101423","article-title":"Azithromycin dosing and preterm premature rupture of membranes treatment (ADAPT): a randomized controlled Phase I trial","volume":"6","author":"Boelig","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2025.09.029_bib14","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1128\/AAC.02011-12","article-title":"Blood, tissue, and intracellular concentrations of azithromycin during and after end of therapy","volume":"57","author":"Matzneller","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ogc.2020.08.005","article-title":"Antibiotics for prophylaxis in the setting of preterm prelabor rupture of membranes","volume":"47","author":"Dotters-Katz","year":"2020","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2025.09.029_bib16","doi-asserted-by":"crossref","first-page":"S807","DOI":"10.1016\/j.ajog.2023.02.002","article-title":"Clinical chorioamnionitis at term: definition, pathogenesis, microbiology, diagnosis, and treatment","volume":"230","author":"Jung","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib17","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1128\/AAC.02210-13","article-title":"In vitro activity of solithromycin against erythromycin-resistant Streptococcus agalactiae","volume":"58","author":"Piccinelli","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib18","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/jac\/43.6.825","article-title":"Comparative in-vitro activity of moxifloxacin, minocycline and azithromycin against Chlamydia spp","volume":"43","author":"Donati","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib19","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0002-9378(89)90527-9","article-title":"Normal amniotic fluid volume changes throughout pregnancy","volume":"161","author":"Brace","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib20","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0002-9378(96)80028-7","article-title":"Mathematic modeling of human amniotic fluid dynamics","volume":"175","author":"Mann","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2025.2496792","article-title":"Influential predictors of azithromycin pharmacokinetics: a systematic review of population pharmacokinetics","volume":"57","author":"Methaneethorn","year":"2025","journal-title":"Ann Med"},{"key":"10.1016\/j.ajog.2025.09.029_bib22","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/AAC.00717-11","article-title":"Influence of body weight, ethnicity, oral contraceptives, and pregnancy on the pharmacokinetics of azithromycin in women of childbearing age","volume":"56","author":"Fischer","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/AAC.00771-09","article-title":"Pharmacokinetic properties of azithromycin in pregnancy","volume":"54","author":"Salman","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib24","doi-asserted-by":"crossref","first-page":"67.e1","DOI":"10.1016\/j.ajog.2019.02.030","article-title":"A contemporary amniotic fluid volume chart for the United States: the NICHD Fetal Growth Studies\u2013Singletons","volume":"221","author":"Owen","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib25","first-page":"520.e1","article-title":"Progesterone inhibits in vitro fetal membrane weakening. In: American Journal of Obstetrics and Gynecology","volume":"213","author":"Kumar","year":"2015","journal-title":"Mosby Inc"},{"key":"10.1016\/j.ajog.2025.09.029_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/mi.2017.35","article-title":"Progesterone-based compounds affect immune responses and susceptibility to infections at diverse mucosal sites","volume":"10","author":"Hall","year":"2017","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.ajog.2025.09.029_bib27","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1128\/AAC.02904-14","article-title":"Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects","volume":"58","author":"Zheng","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/jac\/dky548","article-title":"Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review","volume":"74","author":"Kong","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.03.009","article-title":"Azithromycin vs.Erythromycin for the management of preterm premature rupture of membranes","author":"Navathe","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/10600280231181135","article-title":"Latency antibiotics in preterm prelabor rupture of membranes: a comparison of azithromycin regimens","volume":"58","author":"Day","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2025.09.029_bib31","series-title":"BJOG","article-title":"Timing of prophylactic intrapartum azithromycin administration and efficacy in prevention of maternal and infant infections: a secondary analysis of a randomized controlled trial","author":"Boelig","year":"2025"},{"key":"10.1016\/j.ajog.2025.09.029_bib32","doi-asserted-by":"crossref","first-page":"140.e1","DOI":"10.1016\/j.ajog.2019.03.017","article-title":"Evidence that antibiotic administration is effective in the treatment of a subset of patients with intra-amniotic infection\/inflammation presenting with cervical insufficiency","volume":"221","author":"Oh","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2025.09.029_bib33","doi-asserted-by":"crossref","DOI":"10.1080\/14767058.2023.2286189","article-title":"Antibiotic administration reduced intra-amniotic inflammation 7 days after preterm premature rupture of the membranes with intra-amniotic infection","volume":"36","author":"Ikeda","year":"2023","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2025.09.029_bib34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/infdis\/jit578","article-title":"Transplacental transfer of azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model","volume":"209","author":"Acosta","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ajog.2025.09.029_bib35","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1203\/PDR.0b013e318142582d","article-title":"Azithromycin suppresses activation of nuclear factor-kappa B and synthesis of pro-inflammatory cytokines in tracheal aspirate cells from premature infants","volume":"62","author":"Aghai","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2025.09.029_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1128\/AAC.03951-14","article-title":"Pharmacokinetics, microbial response, and pulmonary outcomes of multidose intravenous azithromycin in preterm infants at risk for Ureaplasma respiratory colonization","volume":"59","author":"Merchan","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2025.09.029_bib37","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41390-019-0408-6","article-title":"Repurposing azithromycin for neonatal neuroprotection","volume":"86","author":"Barks","year":"2019","journal-title":"Pediatr Res"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825006921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937825006921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:52:49Z","timestamp":1781005969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937825006921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0002937825006921"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2025.09.029","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azithromycin in preterm premature rupture of membranes: population pharmacokinetics and dose optimization","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2025.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}